ESR MR Safety and Quality Subcommittee Session - Jointly organised with the European Imaging Biomarkers Alliance (EIBALL)

MR 2 - Imaging biomarkers in clinical practice

Lectures

1
Chairpersons' introduction

Chairpersons' introduction

05:00Michelle Claire Williams, Edinburgh / UK, Afarine Madani, Brussels / BE

2
MRI and biomarkers: current status and future prospectives

MRI and biomarkers: current status and future prospectives

15:00Marion Smits, Rotterdam / NL

3
How do we establish methods and standards for biomarkers in MRI: challenges and goals in quality assurance

How do we establish methods and standards for biomarkers in MRI: challenges and goals in quality assurance

15:00Ioannis Tsougos, Larissa / GR

4
Using the ESR EIBALL Biomarkers Inventory for clinical MRI

Using the ESR EIBALL Biomarkers Inventory for clinical MRI

15:00Aad Van Der Lugt, Rotterdam / NL

5
Panel discussion: Can we begin using biomarkers in clinical practice?

Panel discussion: Can we begin using biomarkers in clinical practice?

10:00Panel discussion: Can we begin using biomarkers in clinical practice?

5 min
Chairpersons' introduction
Michelle Claire Williams, Edinburgh / United Kingdom
Afarine Madani, Brussels / Belgium
15 min
MRI and biomarkers: current status and future prospectives
Marion Smits, Rotterdam / Netherlands
  1. To learn the potential of MRI biomarkers for clinical application.
  2. To appreciate the current limitations of MRI biomarkers.
  3. To understand the pathway towards clinical implementation of MRI biomarkers.
15 min
How do we establish methods and standards for biomarkers in MRI: challenges and goals in quality assurance
Ioannis Tsougos, Larissa / Greece
  1. To learn about the current methodologies used in the identification and validation of MRI-based biomarkers and their role in clinical and research settings.
  2. To appreciate the key challenges in establishing standardised protocols for biomarker quantification and the impact of variability across sites, platforms, and acquisition parameters.
  3. To understand the principles and goals of quality assurance in MRI biomarker development, including reproducibility, harmonisation efforts, and emerging international frameworks.
15 min
Using the ESR EIBALL Biomarkers Inventory for clinical MRI
Aad Van Der Lugt, Rotterdam / Netherlands
  1. To learn about EIBALL and the potential value of quantitative imaging biomarkers.
  2. To appreciate the challenges and solutions of MRI in quantitative imaging biomarker assessment.
  3. To understand the necessary steps to assess reliably and reproducibly.
10 min
Panel discussion: Can we begin using biomarkers in clinical practice?